Catalyst Wire Dossier Catalyst Wire Dossier

64Cu-DOTA-Trastuzumab

Copper-64 DOTA-Trastuzumab · City of Hope Medical Center
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 64Cu-DOTA-Trastuzumab, covering 2026-02-23 to 2026-02-23. Get the full timeline:

Most recent: Clinical Trial Update: An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis [Phase 4]

See pricing